460
Participants
Start Date
March 14, 2017
Primary Completion Date
February 15, 2019
Study Completion Date
September 23, 2020
Rivoceranib
Oral tablet
Placebo
Oral tablet
National Taiwan University Hospital, Taipei
Chang Gung Memorial Hospital - Linko Branch, Taoyuan District
Chi Mei Medical Center - LiouYing Branch, Tainan City
National Cancer Center, Goyang-si
Hudson Valley Cancer Centre, Hawthorne
Taipei Veterans General Hospital, Taipei
Charite - Universitaetsmedizin Berlin - Medizinische Klinik mit Schwerpunkt Haematologie, Onkologie und Tumorimmunologie, Berlin
Seoul National University Bundang Hospital, Gyeonggi-do
Hallym University Sacred Heart Hospital, Anyang-si
Ajou University Hospital, Suwon
Fondazione IRCCS-Istituto Nazionale Tumori, Milan
Facharztzentrum Eppendorf - Haematologisch-Onkologische Praxis Eppendorf (HOPE), Hamburg
"Communal Institution Vinnytsia Regional Clinical Oncology Dispensary", Vinnytsia
Gachon University Gil Medical Center, Incheon
Ospedale di Piacenza - Oncology and heamatology, Piacenza
Institut Regional du Cancer Montpellier (ICM), Montpellier
Chungnam National University Hospital, Daejeon
Universitätsklinik Marburg, Klinik fur Innere Medizin, Schwerpunkt Haematologie, Onkologie und Immunologie, Marburg
Veneto Oncology Institute (IOV-IRCCS), Melanoma & Esophageal Oncology Unit, Padua
China Medical University Hospital, Taichung
Policlinico di Modena-Azienda Ospedaliero Universitaria di Modena.Oncologia ed Ematologia., Modena
Chungbuk National University Medical Center, Chuncheon
Kyungpook National University Medical Center, Daegu
Keimyung University Dongsan Medical Center, Daegu
IRCCS/Arcispedale Santa Maria Nuova, Reggio Emilia
Yeungnam University Medical Center, Daegu
Ulsan University Hospital, Ulsan
Rimini Hospital, Rimini
U.O Di Oncologia Ospedale Degli Infermi, Faenza
Inje University Haeundae Paik Hospital, Busan
Karmanos Cancer Institute, Detroit
Dnipropetrovsk Medical Academy, Department of Oncology, Dnipro
Dong-A University Hospital, Busan
Pusan National University Hospital, Busan
"Municipal Institution Kryvyi Rig Oncology Dispensary, Chemotherapy Department", Kryvyi Rih
Chungbuk National University Hospital, Jungbuk
Mayo Clinic Cancer Center, Rochester
"Ospedale Felice Lotti", Pontedera
Ospedali Riuniti di Ancona - SOD Clinica Oncologica, Torrette
"Institut für Klinisch-Onkologische Forschung (IKF) Krankenhaus Nordwest gGmbH UCT - Universitäres Centrum für Tumorerkrankungen Frankfurt", Frankfurt
"Communal Institution Kharkiv Regional Clinical Oncology Center , Chemotherapy department #1, Medical Academy of Postgraduate Education, Oncology and Pediatric Oncology", Kharkiv
Centre Leon-Berard (CLB), Lyon
"State institution Zaporizhzhia Medical Academy of Postgraduate Education MOH Ukraine, Department of oncology based on Municipal Institution Zaporizhzhia Regional Clinical Oncology Dispensary Zaporizhzhia Regional Assembly", Zaporizhzhia
National CHeng Kung University Hospital, Tainan City
Highlands Oncology Group, Rogers
Kherson Regional Oncological Dispensary, Kherson
"Communal Institution Ivano-Frankivsk Regional Oncological Center", Ivano-Frankivsk
Kaohsiung Medical University Hospital, Kaohsiung City
Chang Gung Memorial Hospital - Kaohsiung Branch, Kaohsiung City
Mayo Clinic Phoenix, Scottsdale
"Communal Institution Transcarpathian Regional Clinical Oncological Center", Uzhhorod
Magna Graecia University- Department of Experimental and Clinical Medicine, Catanzaro
Centre Hospitalier Franco-Britannique; Oncologie Médicale, Levallois-Perret
Institut Gustave Roussy, Villejuif
"State Budgetary Healthcare Institution of Arkhangelsk Region Arkhangelsk Clinical Oncology Dispensary", Arkhangelsk
"Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Heaithcare of the Russian Federation", Saint Petersburg
"Centrul de Oncologie Sf. Nectarie, Sectia de Oncologie Medicala", Craiova
"Budgetary Healthcare Institution of Orel Region Orel Oncology Dispensary", Oryol
"State Healthcare Institution Kursk Regional Clinical Oncology Dispensary", Kursk
"State Budgetary Healthcare Institution of Stavropol Territory Pyatigorsk Oncology Dispensary", Pyatigorsk
"Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj-Napoca, Sectia de Radioterapie I", Cluj-Napoca
S.C. Medisprof S.R.L., Cluj-Napoca
Ogarev Mordovia State University, Saransk
"State Budgetary Healthcare Institution Republican Clinical Oncology Dispensary", Ufa
Saint Constantin Hospital (TEO HEALTH SA), Brasov
Omsk regional clinical oncology center, Omsk
Centre Antoine-Lacassagne, Nice
Hyogo Cancer Center, Hyōgo
Chiba Cancer Center, Chiba
National Cancer Center Hospital, Tokyo
Kyushu University Hospital, Fukuoka
National Cancer Center Hospital East, Chiba
St. Marianna University School of Medicine Hospital, Kanagawa
Saitama Cancer Center, Saitama
Japan Community Health Care Organization Kyushu Hospital, Fukuoka
The Cancer Institute Hospital of Japanese Foundation For Cancer Research, Tokyo
National Hospital Organization Shikoku Cancer Center, Ehime
Saku Central Hospital Advanced Care Center, Nagano
Hokkaido University Hospital, Hokkaido
Keio University Hospital, Tokyo
Osaka University Hospital, Osaka
Aichi Cancer Center Hospital, Nagoya
Szpital Uniwersytecki w Krakowie, Odział Kliniczny Onkologii, Krakow
Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie, Klinika Gastroenterologii Onkologicznej, Warsaw
Korea University Anam Hospital, Seoul
Severence Hospital, Yonsei University Health System, Seoul
Veterans Health Service (VHS) Medical Center, Seoul
ASAN Medical Center, Seoul
Gangnam Severance Hospital, Seoul
Samsung Medical Center, Seoul
Korea University Guro Hospital, Seoul
"Municipal Institution Kyiv City Clinical Oncological Center", Kyiv
Royal Marsden Hospital London, London
The Christie NHS Foundation Trust, Manchester
Royal Marsden Hospital Surrey, Sutton
Lead Sponsor
Elevar Therapeutics
INDUSTRY